March 2014

At UnitedHealth Group, their mission is to help people live healthier lives. To achieve this goal, they are focused on building a modern, adaptable, innovative and inclusive system of health care services.
Their scale and potential to improve health makes them one of the most visible stewards of America’s vast health care system. Entrusted with both important resources and responsibilities, they are involved on a daily basis in decision-making that has life-changing consequences for millions of Americans.

Post: Research Analyst - Medical Writing & Publishing-547650

Aspiring-Solutions hiring for its Pharma MNC Client. Our client is a engaged in manufacturing & exporting of specialty products.

Post: Regulatory Affairs Manager (1 opening)

The Institute of Chemical Technology (ICT) Mumbai was established as the Department of Chemical Technology on 1^st October, 1933 by the University of Mumbai, through active support of industries and philanthropists. The Institute was most popularly known as UDCT, Mumbai. Research has been an integral part of ICT since its inception and it has created over 500 first generation entrepreneurs. The UDCT grew significantly in stature and was granted autonomy under UGC regulations by the University of Mumbai and further converted in to an Institute on 26th January, 2002. Under the World Bank TEQIP programme, the Maharashtra government granted it full autonomy in June 2004. Due to the recommendations of the Government of Maharashtra and University of Mumbai, the ICT was granted Deemed University Status by the MHRD on 12th September, 2008, with all provisions of the UGC for funding and support as the state owned deemed university.

APPLICATTON FOR RESEARCH ASSOCTATE (RA) ON A RESEARCH PROJECT SPONSORED BY INDIAN COUNCIL OF MEDICAL RESEARCH, NEW DELHI

Applications invited under national rual health mission

Post: AYUSH Pharmacist

Bristol-Myers Squibb Company and Pfizer Inc. announced that the U.S. Food and Drug Administration (FDA) approved a Supplemental New Drug Application (sNDA) for Eliquis (apixaban) for the prophylaxis of deep vein thrombosis (DVT), which may lead to pulmonary embolism (PE), in patients who have undergone hip or knee replacement surgery.